Pyridazine-3-carbaldehyde

Catalog No.: 
ACJVBW741
CAS No.: 
60170-83-4
Molecular Formula: 
C5H4N2O
Molecular Weight: 
108.10
Pyridazine-3-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$76.00In stockInquiry
250mg98%$109.00In stockInquiry
1g98%$275.00In stockInquiry
5g98%$864.00In stockInquiry
25g98%$3429.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NamePyridazine-3-carbaldehyde
IUPAC Namepyridazine-3-carbaldehyde
MDL No.MFCD04972627
Molecular FormulaC5H4N2O
Molecular Weight108.10
SMILESO=CC1=NN=CC=C1
InChI KeyYRUFRSUZZACWCW-UHFFFAOYSA-N
Synonym3-PYRIDAZINECARBALDEHYDE,97%;3-Pyridazinecarbaldehyde;3-Pyridazinecarboxaldehyde (6CI, 9CI);3-Pyridazinecarboxaldehyde;Pyridazine-3 carboxaldehyde;pyridazine-3-carbaldehyde;3-PYRIDAZINECARBALDEHYDE,97% ISO 9001:2015 REACH
CAS No.60170-83-4
PubChem CID13011727

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACJVBW741 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTWVG652 route compound structure diagram
    ACTWVG65237444-46-5In Stock
  2. Then
  3. ACJVBW741 route product structure diagram
    ACJVBW74160170-83-4In Stock
Inquiry

2. ACJVBW741 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNMJX619 route compound structure diagram
    ACNMJX6191120-95-2In Stock
  4. Then
  5. ACJVBW741 route product structure diagram
    ACJVBW74160170-83-4In Stock
Inquiry

3. ACJVBW741 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJVBW741 route product structure diagram
    ACJVBW74160170-83-4In Stock
Inquiry

Comments (0)